Dr. Jurgi Camblong is a molecular biologist. He obtained his PhD at University of Geneva, and was trained as a postdoctoral fellow at Sir William Dunn School of Pathology, University of Oxford. His interests revolved around gene expression, genome looping, bi-directional transcription and gene silencing.
Dr. Camblong's current focus is on genomics. The technology of the company he founded, SOPHiA GENETICS, is used by over 400 hospitals across 55 countries and has already analyzed the genomic profiles of over 160K patients. Dr. Camblong won the Entrepreneur of the Year Award of Ernst & Young Switzerland.